APLLTD

Expands in the U.S.🚀💊

is 2.2% up today with 17+ points upward. REASON? Its wholly owned subsidiary, Alembic Global Holding SA, has strengthened its global footprint by incorporating Alembic Lifesciences Inc. in the United States. To establish full control, Alembic Global Holding SA will remit funds for 100% shareholding in the newly formed entity. This move reinforces Alembic’s international presence, tapping into the lucrative $560 billion U.S. pharmaceutical market, known for its high-margin generics and specialty drugs. 🚀